Cellular-Based Therapy for Osteonecrosis

Orthopedic Clinics of North America

Volumn 40, Issue 2, 2009, Pages 213-221

  Gangji, Valérie ^a   Hauzeur, Jean Philippe ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Bone marrow; Cellular therapy; Osteonecrosis; Stem cell

Indexed keywords

ADULT STEM CELL; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BONE NECROSIS; BONE REMODELING; CLINICAL TRIAL; FEMUR HEAD; FEMUR HEAD NECROSIS; HUMAN; IMPLANTATION; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; PSEUDARTHROSIS; REVIEW; STEM CELL TRANSPLANTATION; THERAPY EFFECT; VASCULAR DISEASE; VASCULAR SURGERY;

BONE MARROW CELLS; BONE REMODELING; HUMANS; OSTEONECROSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 63549084215     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2008.10.009     Document Type: Review

References (71)

1. Lieberman J.R., Berry D.J., Mont M.A., et al. Osteonecrosis of the hip: management in the 21st century. J Bone Joint Surg Am 52 (2003) 337-355
2. Hernigou P., and Beaujean F. Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. J Bone Joint Surg Am 79 (1997) 1047-1053
3. Hernigou P., Beaujean F., and Lambotte J.C. Decrease in the mesenchymal stem cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br 81 (1999) 349-355
4. Gangji V., Hauzeur J.P., Schoutens A., et al. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30 (2003) 348-351
5. Gangji V., Hauzeur J.P., Matos C., et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone marrow cells: a pilot study. J Bone Joint Surg Am 86-A (2004) 1153-1160
6. Hernigou P., and Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop 405 (2002) 14-23
7. Hauge E.M., Qvesel D., Eriksen E.F., et al. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16 (2001) 1575-1582
8. Everts V., Delaisse J.M., Korper W., et al. The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17 (2002) 77-90
9. Bonewald L.F. Osteocyte messages from a bony tomb. Cell Metab 5 (2007) 410-411
10. Parfitt A.M. The mechanism of coupling: a role for the vasculature. Bone 26 (2000) 319-323
11. Eriksen E.F., Eghbali-Fatourechi G.Z., and Khosla S. Remodeling and vascular spaces in bone. J Bone Miner Res 22 (2007) 1-6
12. Jones Jr. J.P. Fat embolism and osteonecrosis. Orthop Clin North Am 16 (1985) 595-633
13. Wang G.J., Sweet D.E., Reger S.I., et al. Fat cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am 59 (1977) 729-735
14. Simkin P.A., and Downey D.J. Hypothesis: retrograde embolization of marrow fat may cause osteonecrosis. J Rheumatol 14 (1987) 870-872
15. Glueck C.J., Freiberg R.A., Fontaine R.N., et al. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 386 (2001) 19-33
16. Fisher D.E. The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin Orthop 130 (1978) 68-80
17. Calder J.D., Pearse M.F., and Revell P.A. The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br 83 (2001) 419-422
18. O'Brien C.A., Jia D., Plotkin L.I., et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145 (2004) 1835-1841
19. Weinstein R.S., Jilka R.L., Parfitt A.M., et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102 (1998) 274-282
20. Hauzeur J.P., Perlmutter N., Appelboom T., et al. Medullary impairment at early stage of non-traumatic osteonecrosis of the femoral head. Rheumatol Int 11 (1991) 215-217
21. Weinstein R.S., Nicholas R.W., and Manolagas S.C. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85 (2000) 2907-2912
22. Shih M.S., Cook M.A., Spence C.A., et al. Relationship between bone formation rate and osteoblast surface on different subdivisions of the endosteal envelope in aging and osteoporosis. Bone 14 (1993) 519-521
23. Slack J.M. Stem cells in epithelial tissues. Science 287 (2000) 1431-1433
24. Jones E.A., Kinsey S.E., English A., et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46 (2002) 3349-3360
25. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
26. Schor A.M., Canfield A.E., Sutton A.B., et al. Pericyte differentiation. Clin Orthop Relat Res 313 (1995) 81-91
27. De B.C., Dell'Accio F., Vandenabeele F., et al. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160 (2003) 909-918
28. Black I.B., and Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol Dis 27 (2001) 632-636
29. Weissman I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100 (2000) 157-168
30. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
31. Connolly J., Guse R., Lippiello L., et al. Development of an osteogenic bone marrow preparation. J Bone Joint Surg Am 71 (1989) 684-691
32. Muschler G.F., Boehm C., and Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am 79 (1997) 1699-1709
33. Patterson T.E., Kumagai K., Griffith L., et al. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 90 Suppl 1 (2008) 111-119
34. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
35. Connolly J.F. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res 313 (1995) 8-18
36. Tuli R., Seghatoleslami M.R., Tuli S., et al. A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol 23 (2003) 37-49
37. Muschler G.F., Midura R.J., and Nakamoto C. Practical modeling concepts for connective tissue stem cell and progenitor compartment kinetics. J Biomed Biotechnol 2003 (2003) 170-193
38. Metheny-Barlow L.J., Tian S., Hayes A.J., et al. Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF. Microvasc Res 68 (2004) 221-230
39. Pountos I., Jones E., Tzioupis C., et al. Growing bone and cartilage: the role of mesenchymal stem cells. J Bone Joint Surg Br 88 (2006) 421-426
40. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5 (1999) 309-313
41. Horwitz E.M., Gordon P.L., Koo W.K., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 99 (2002) 8932-8937
42. Grundel R.E., Chapman M.W., Yee T., et al. Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop Relat Res 266 (1991) 244-258
43. Bruder S.P., Kraus K.H., Goldberg V.M., et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80 (1998) 985-996
44. Hollinger J.O., Brekke J., Gruskin E., et al. Role of bone substitutes. Clin Orthop Relat Res 324 (1996) 55-65
45. Johnson K.D., Frierson K.E., Keller T.S., et al. Porous ceramics as bone graft substitutes in long bone defects: a biomechanical, histological, and radiographic analysis. J Orthop Res 14 (1996) 351-369
46. Cook S.D., Baffes G.C., Wolfe M.W., et al. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 301 (1994) 302-312
47. Gerhart T.N., Kirker-Head C.A., Kriz M.J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 293 (1993) 317-326
48. Goel A., Sangwan S.S., Siwach R.C., et al. Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 36 (2005) 203-206
49. Siwach R.C., Sangwan S.S., Singh R., et al. Role of percutaneous bone marrow grafting in delayed unions, non-unions and poor regenerates. Indian J Med Sci 55 (2001) 326-336
50. Hernigou P., Poignard A., Beaujean F., et al. Percutaneous autologous bone marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87 (2005) 1430-1437
51. Hernigou P., Poignard A., Manicom O., et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 87 (2005) 896-902
52. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
53. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
54. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
55. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
56. Rehman J., Li J., Orschell C.M., et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
57. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94 (2004) 230-238
58. Shyu K.G., Manor O., Magner M., et al. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98 (1998) 2081-2087
59. Wang Y., Wan C., Deng L., et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117 (2007) 1616-1626
60. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone marrow stem cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
61. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
62. Tse H.F., Kwong Y.L., Chan J.K., et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
63. Hernigou P., and Bernaudin F. [Course of bone tissue after bone marrow allograft in adolescents with sickle cell disease]. Rev Chir Orthop Reparatrice Appar Mot 80 (1994) 138-143
64. Hernigou P., Bernaudin F., Reinert P., et al. Bone marrow transplantation in sickle cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. J Bone Joint Surg Am 79 (1997) 1726-1730
65. Johnson E.E., and Urist M.R. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop Relat Res 371 (2000) 61-74
66. Lieberman J.R., Conduah A., and Urist M.R. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res 429 (2004) 139-145
67. Radomsky M.L., Thompson A.Y., Spiro R.C., et al. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop Relat Res 355 (1998) S283-S293
68. Yang C., Yang S.H., Du J.Y., et al. Basic fibroblast growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head. Chin Med Sci J 19 (2004) 111-115
69. Bostrom M.P., and Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res 355 (1998) S124-S131
70. Healey J.H., Zimmerman P.A., McDonnell J.M., et al. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 256 (1990) 280-285
71. Connolly J.F., Guse R., Tiedeman J., et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 366 (1991) 259-270